16065-Lymphomas-Non-Hodgkins-497

Lymphomas

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin�s Lymphoma (UTX-TGR-205)

  • Details

ClinicalTrials.gov ID: NCT02793583
Diagnosis Type: Non-Hodgkins
USOR Number:

  • Address

1200 Brooklyn Ave, Suite 115
San Antonio, TX 78212
P: (210) 224-6531

Search by practice name, trial titles, indicators and specific disease types.